Iq Eq Fund Management (Ireland) LTD Guardant Health, Inc. Transaction History
Iq Eq Fund Management (Ireland) LTD
- $1.09 Billion
- Q2 2025
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Guardant Health, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 45,324 shares of GH stock, worth $2.96 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
45,324
Previous 9,004
403.38%
Holding current value
$2.96 Million
Previous $383,000
515.67%
% of portfolio
0.22%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding GH
# of Institutions
416Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$795 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$734 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$325 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$314 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$278 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.68B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...